Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, December 22, 2009, 11:43PM ET - U.S. Markets Closed. Dow Up 0.49% Nasdaq Up 0.67%
Cell Therapeutics, Inc. (CTIC)At 4:00PM ET: 1.142  Down 0.038 (3.22%)  
MORE ON CTIC
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Today, Tue, Dec 22, 2009
Cell Therapeutics Commits to PhRMA's Code on Interactions With Healthcare Professionals
PR Newswire (Tue 1:30am)
Mon, Dec 21, 2009
UPDATE - CTI says cancer drug gets orphan status in Europe
at Reuters (Mon 7:20am)
European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
PR Newswire (Mon 1:30am)
Fri, Dec 18, 2009
CELL THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Dec 18)
Biotech Stock Mailbag: Year in Review
at TheStreet.com (Fri, Dec 18)
Thu, Dec 17, 2009
CELL THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi
EDGAR Online (Thu, Dec 17)
Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010
PR Newswire (Thu, Dec 17)
Wed, Dec 16, 2009
3 Reasons You Should Ignore Everyone's Predictions for 2010
at Motley Fool (Wed, Dec 16)
Cell Therapeutics Gets FDA Panel for Lymphoma Drug: BioBuzz
at TheStreet.com (Wed, Dec 16)
Tue, Dec 15, 2009
Biotech Calendar: Upcoming FDA Dates
at TheStreet.com (Tue, Dec 15)
Fri, Dec 11, 2009
Biotech Stock Mailbag: Cell Therapeutics
at TheStreet.com (Fri, Dec 11)
Stock Watch: Beacon Equity Issues Market Alert for Cell Therapeutics Inc.
GlobeNewswire (Fri, Dec 11)
Wed, Dec 9, 2009
A Strategy for All Situations
at Motley Fool (Wed, Dec 9)
Cell Therapeutics' Positive Data
Zacks.com (Wed, Dec 9)
Tue, Dec 8, 2009
Cell Therapeutics on Dilution Watch: BioBuzz
at TheStreet.com (Tue, Dec 8)
Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines
PR Newswire (Tue, Dec 8)
Mon, Dec 7, 2009
Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data
PR Newswire (Mon, Dec 7)
Wed, Dec 2, 2009
New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology
PR Newswire (Wed, Dec 2)
Tue, Dec 1, 2009
Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast
PR Newswire (Tue, Dec 1)
Mon, Nov 30, 2009
CELL THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi
EDGAR Online (Mon, Nov 30)
Older Headlines - Download Recent Headlines
View headlines from:
Add CTIC News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage